More than 40% of patients presenting with acute bacterial skin and skin structure infection
(ABSSSI) to the Barnes-Jewish Hospital (BJH) emergency department (ED) are admitted for
intravenous antibiotics. There is growing evidence to suggest that many hospital admissions
for uncomplicated ABSSSI due to Gram-positive bacteria could be avoided with an alternative
treatment strategy employing newer long-acting antibiotics. Coupled with close outpatient
follow-up, such an alternative hospital avoidance strategy has the potential to improve
quality and value of care for patients with uncomplicated ABSSSI and optimize use of limited
inpatient healthcare resources.
Phase:
Phase 4
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
Allergan The Foundation for Barnes-Jewish Hospital